scholarly article | Q13442814 |
P356 | DOI | 10.1165/AJRCMB/6.4.359 |
P698 | PubMed publication ID | 1312850 |
P50 | author | Jeffrey A Kern | Q63373813 |
P2093 | author name string | A. Gazdar | |
R. A. Robinson | |||
D. B. Weiner | |||
L. Torney | |||
P2860 | cites work | Isolation of biologically active ribonucleic acid from sources enriched in ribonuclease | Q26778460 |
A technique for radiolabeling DNA restriction endonuclease fragments to high specific activity | Q26778490 | ||
Studies of the HER-2/neu proto-oncogene in human breast and ovarian cancer | Q29547699 | ||
Ribonucleic acid isolated by cesium chloride centrifugation | Q29616561 | ||
Number and evolutionary conservation of alpha- and beta-tubulin and cytoplasmic beta- and gamma-actin genes using specific cloned cDNA probes | Q34272920 | ||
Direct interaction of a ligand for the erbB2 oncogene product with the EGF receptor and p185erbB2. | Q41721035 | ||
A point mutation in the neu oncogene mimics ligand induction of receptor aggregation | Q44611984 | ||
Abnormalities of protooncogenes in non-small cell lung cancer. Correlations with tumor type and clinical characteristics. | Q45946068 | ||
Similarity of protein encoded by the human c-erb-B-2 gene to epidermal growth factor receptor | Q48369441 | ||
The neu oncogene: an erb-B-related gene encoding a 185,000-Mr tumour antigen | Q52827123 | ||
P433 | issue | 4 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | proto-oncogene | Q30555 |
P304 | page(s) | 359-363 | |
P577 | publication date | 1992-04-01 | |
P1433 | published in | American Journal of Respiratory Cell and Molecular Biology | Q4744268 |
P1476 | title | Mechanisms of p185HER2 expression in human non-small cell lung cancer cell lines | |
P478 | volume | 6 |
Q34073788 | Bronchoalveolar lavage neuregulin-1 is elevated in acute lung injury and correlates with inflammation |
Q34124421 | C-erbB-2 expression and codon 12 K-ras mutations both predict shortened survival for patients with pulmonary adenocarcinomas. |
Q27002075 | Human epidermal growth factor receptor signaling in acute lung injury |
Q41524948 | Inhibition of human lung cancer cell line growth by an anti-p185HER2 antibody. |
Q44120928 | Neuregulin-1 activates the JAK-STAT pathway and regulates lung epithelial cell proliferation. |
Q52169558 | Neuregulin-1 and human epidermal growth factor receptors 2 and 3 play a role in human lung development in vitro. |
Q34695953 | Neuregulin-1-human epidermal receptor-2 signaling is a central regulator of pulmonary epithelial permeability and acute lung injury. |
Q34679340 | Non-small cell lung cancer clinical trials with trastuzumab: their foundation and preliminary results |
Q35252008 | Overexpression of the p185erB-2 tyrosine kinase growth factor receptor: control or chaos |
Q26865861 | Pulmonary epithelial barrier function: some new players and mechanisms |
Q40616262 | Small interfering RNA (siRNA) inhibits the expression of the Her2/neu gene, upregulates HLA class I and induces apoptosis of Her2/neu positive tumor cell lines. |
Q36292265 | The role of transforming growth factor alpha production and ErbB-2 overexpression in induction of tumorigenicity of lung epithelial cells |
Q74800297 | [CYFRA 21.1 cytosol levels in lung adenocarcinomas. Correlation with other clinico-biological parameters] |
Search more.